Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Deferred income

v3.23.1
Deferred income
 12 Months Ended
Dec. 31, 2022
Deferred income

18. Deferred income

 

Year ended December 31, 2022

 

    Contracts with customers  
    £  
At January 1, 2022     3,844,533  
Released to the statement of profit or loss     (3,844,533 )
At December 31, 2022     -  

 

Year ended December 31, 2021

 

    Contracts with customers  
    £  
At January 1, 2021     5,823,192  
Released to the statement of profit or loss     1,978,659  
At December 31, 2021     3,844,533  
         
Current     1,978,660  
Non-current     1,865,873  

 

 

TC BIOPHARM (HOLDINGS) PLC

 

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (CONTINUED)

 

18. Deferred income (continued)

 

Movement in the period reflects the release of deferred income in respect of the long-term research and development collaboration agreements.